Home › Mutual Funds › Tata Mutual Fund › Tata India Pharma & Healthcare Fund Regular Growth
Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Regular Growth

Add To Compare

31.743 (0.379%)
NAV on June 19, 2026
Category Equity:
Sector - Healthcare
Investment StyleBox
Mid Growth
Total Assets 1,387 cr
Turnover Ratio 11.18%
Expense Ratio 1.84%
Exit Load 0.25%if redeemed within
30 Days0.00%if redeemed after 30 Days
Returns
  • 1M: -0.22%
  • 1Y: 8.28%
  • 3M: 11.61%
  • 3Y: 21.40%
  • 6M: 5.12%
  • 5Y: 13.78%
Min Investment 5,000
ADDITIONAL INFO
Fund Manager Rajat Srivastava (Since almost 2 years)
ISIN INF277K016A9
Fund Family Tata
P/E Ratio 40.45
P/B Ratio 6.40
Launch Date December 28, 2015
Benchmark Nifty Pharma TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs Nifty Pharma TR INR

Alpha -1.74
Beta 0.98
R-Squared 94.09
Info Ratio -0.62
Tracking Err 4.16
Sortino 1.575
Sharpe 0.918
Std Dev 17.097
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.4%
Industrial 0.0%
Technology 0.0%
Basic Materials 3.99%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 94.26%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 1.36%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

View Factsheet
-
Best Sector Healthcare Funds
NAME LATEST
NAV		 RETURNS
1y     		FUND
ASSETS		 Expense
RATIO		 RISK
Mirae
Mirae Asset Healthcare Fund Direct Growth
48.061 16.55% 3,091 cr 0.44% -
Uti
UTI Healthcare Fund-Growth Option- Direct
360.616 15.09% 1,217 cr 1.21% -
Icici
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth
45.330 9.86% 6,454 cr 0.87% -


Other plans of Tata India Pharma & Healthcare


Other Equity funds by Tata

Data Partner
Click here to visit AMC website and
read all scheme related documents Tata Fund